2014 ASH State-of-the-Art Symposium

The American Society of Hematology
Last Modified: May 22, 2014

Share article


Dates: October 17-18, 2014
Location: Baltimore, Maryland

Sponsoring Group: The American Society of Hematology

Web Page URL: www.hematology.org/sas_calendar

Topics Covered: Clinical updates in hematology with a focus on lymphoid malignancies.

Objectives: The ASH® State-of-the-Art Symposium (SAS) provides up-to-date, evidence-based continuing medical education that spans the medical field and practice of hematology. The smaller, clinically focused program format provides attendees with ample opportunities to discuss their actual patient cases and practice challenges with experts in the field.

Who Should Attend: Hematologists, Hematologist-Oncologists

Continuing Education: Yes


News
ASH: CALR Mutations ID'd in Myeloproliferative Neoplasms

Dec 11, 2013 - Many patients with myeloproliferative neoplasms without mutations in the Janus kinase 2 gene (JAK2) or in the thrombopoietin receptor gene (MPL) have mutations in the CALR gene encoding calreticulin, according to two studies published online Dec. 10 in the New England Journal of Medicine. The research was published to coincide with presentation at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in New Orleans.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More